We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

102 hedge funds and large institutions have $157M invested in Zomedica Corp. in 2021 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,314% more capital invested

Capital invested by funds: $11.1M → $157M (+$146M)

914% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 7

217% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 6

168% more funds holding

Funds holding: 38102 (+64)

Holders
102
Holders Change
+64
Holders Change %
+168.42%
% of All Funds
1.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
71
Increased
19
Reduced
6
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$64.4M +$35M +21,435,752 +111%
BlackRock
2
BlackRock
New York
$27.1M +$14.2M +8,714,893 +103%
Cambridge Investment Research Advisors
3
Cambridge Investment Research Advisors
Iowa
$19.4M +$307 +188 +0%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$11.7M +$6.1M +3,734,634 +101%
State Street
5
State Street
Massachusetts
$8.49M +$8.78M +5,373,337 New
HF
6
HRT Financial
New York
$3.6M +$3.72M +2,279,287 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$3.43M +$3.55M +2,170,555 New
Citadel Advisors
8
Citadel Advisors
Florida
$3.19M +$2.1M +1,283,339 +174%
Northern Trust
9
Northern Trust
Illinois
$3M +$1.72M +1,054,409 +125%
Millennium Management
10
Millennium Management
New York
$2.2M +$2.17M +1,327,558 +2,116%
Goldman Sachs
11
Goldman Sachs
New York
$1.47M +$1.52M +927,827 New
ECM
12
ExodusPoint Capital Management
New York
$1.31M +$1.35M +828,950 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$756K +$782K +478,311 New
VF
14
Virtu Financial
New York
$739K +$765K +468,023 New
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$613K +$634K +387,800 New
Charles Schwab
16
Charles Schwab
California
$544K +$562K +343,967 New
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$496K +$141K +86,424 +38%
JP Morgan Chase
18
JP Morgan Chase
New York
$416K +$430K +263,032 New
Rafferty Asset Management
19
Rafferty Asset Management
New York
$264K +$273K +167,066 New
GAM
20
Gotham Asset Management
New York
$236K +$244K +149,269 New
Victory Capital Management
21
Victory Capital Management
Texas
$233K +$97.8K +59,870 +68%
Osaic Holdings
22
Osaic Holdings
Arizona
$193K +$145K +88,744 +269%
TI
23
Tidal Investments
Wisconsin
$178K +$185K +112,965 New
KIG
24
Kessler Investment Group
Indiana
$177K +$183K +111,725 New
CAN
25
Cetera Advisor Networks
California
$173K +$179K +109,500 New

ZOM Hedge Fund Activity: Q1 2021 in Review

102 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2021, worth a combined $157M — up 1,314% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new ZOM positions and 7 closed out — a net gain of 64 holders — while 19 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $35M. The largest seller was Winton Group, exiting entirely with an estimated $321K sold.

  • 102 institutional investors held Zomedica Corp. (ZOM) as of Q1 2021, up from 38 in Q4 2020.
  • Funds reported $157M of Zomedica Corp. stock for Q1 2021, up 1,314% quarter-over-quarter.
  • 71 funds opened new Zomedica Corp. positions in Q1 2021 and 7 closed out, a net change of +64 holders.
  • The largest Zomedica Corp. buyer in Q1 2021 was Vanguard Group, an estimated $35M added.
  • The largest Zomedica Corp. seller in Q1 2021 was Winton Group, an estimated $321K sold.

Based on aggregated 13F filings for Q1 2021.